Try a new search

Format these results:

Searched for:

in-biosketch:true

person:steing06

Total Results:

184


Orthotopic neobladder versus Indiana pouch in women: a comparison of health related quality of life outcomes

Large, Michael C; Katz, Mark H; Shikanov, Sergey; Eggener, Scott E; Steinberg, Gary D
PURPOSE/OBJECTIVE:Little is known about the health related quality of life of women who have undergone continent urinary diversion. We compared health related quality of life outcomes for women who underwent radical cystectomy with an orthotopic neobladder or Indiana pouch. MATERIALS AND METHODS/METHODS:From 1995 to June 2008 a single surgeon (GDS) performed radical cystectomy with an orthotopic neobladder in 47 women and radical cystectomy with an Indiana pouch in 45. A comprehensive database provided clinical, pathological and outcomes data. The validated Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index was mailed to 92 patients. RESULTS:Complete data were available for 87% of patients treated with radical cystectomy with an orthotopic neobladder and 93% of those treated with radical cystectomy with an Indiana pouch, with a median followup of 34 and 24 months, respectively (p = 0.8). Median (IQR) age was 65 (58, 71) and 61.5 (51, 67) years for patients with an orthotopic neobladder and Indiana pouch, respectively (p = 0.03). No significant differences were found for pathological stage, nodal status, blood loss, Clavien grade III or greater complications, adjuvant therapy or hospital stay between the 2 treatment groups, or between respondents and nonrespondents. Five-year survival rates for patients with an orthotopic neobladder and Indiana pouch were 65% and 58%, respectively (p = 0.9). There were 21 (75%) living patients with an orthotopic neobladder and 19 (61%) with an Indiana pouch who completed the Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index, and physical (p = 0.53), social (p = 0.97), emotional (p = 0.61), functional (p = 0.55) and radical cystectomy specific (p = 0.54) health related quality of life domains were not significantly different between the groups. CONCLUSIONS:Women undergoing radical cystectomy with an orthotopic neobladder vs an Indiana pouch have similar health related quality of life outcomes. Larger series with longer followup and multiple surgeons are necessary to confirm these findings.
PMID: 19913836
ISSN: 1527-3792
CID: 3725112

Evolution of open radical retropubic prostatectomy--how have open surgeons responded to the challenge of minimally invasive surgery?

Acharya, Sujeet S; Zorn, Kevin C; Shikanov, Sergey; Thong, Alan; Zagaja, Gregory P; Shalhav, Arieh L; Steinberg, Gary D
INTRODUCTION/BACKGROUND:With the advent of minimally invasive surgery (MIS) for treating urologic malignancies, emphasis has been placed on reducing patient morbidity and resuming normal activity. We sought to clarify whether open surgeons (OS) have modified their techniques, surgical equipment, and perioperative management in response to this trend. METHODS:A survey sent to all members of the Society of Urologic Oncology assessed changes that OS performing radical retropubic prostatectomy have made in analgesia, operative technique, perioperative management, and follow-up patterns. We also assessed OS sense of competition from MIS. Surgeon perception of the influence MIS had on these changes was scored from 0 to 4 (0 = not at all, 1 = slightly, 2 = moderately, 3 = greatly, 4 =completely). Overall and major influence by MIS included scores 1-4 and 3-4, respectively. RESULTS:Reduced radical retropubic prostatectomy (RRP) case volume because of MIS competition was reported by 20 OS (24%), with 27 OS (32%) starting to perform MIS, and 20 (24%) doing mostly/exclusively MIS. MIS has influenced OS to reduce incision length (overall influence 56%/major influence 33%), operative time (40%/12%), blood loss (31%/17%), and transfusion rate (33%/14%). MIS has influenced OS to use new instruments (48%/44%) or loupes (20%/9%), modify dissection (45%/31%) or anastomotic technique (14%/12%), and increase the use of hemostatic agents (48%/19%). MIS has reduced convalescence in OS patients by reducing length of stay (52%/28%), time to a regular diet (40%/18%), duration of drain (21%/16%) and Foley (32%/15%), time to return to work (49%/25%), and exercise (44%/21%). MIS has changed follow-up of OS patients by increasing the use of clinical pathways (14%/9%) and validated questionnaires (22%/13%). CONCLUSIONS:To date, the influence of MIS on the OS has not been comprehensively assessed. This survey finds that OS report that MIS serves as major competition to the open technique and that it has influenced them to modify their surgical technique, reduce convalescence, and alter follow-up recommendations.
PMID: 19630483
ISSN: 1557-900x
CID: 3725092

Editorial comment [Editorial]

Katz, Mark H; Steinberg, Gary D
PMID: 19758644
ISSN: 1527-3792
CID: 3725102

Editorial comment [Comment]

Katz, Mark H; Steinberg, Gary D
PMID: 19683291
ISSN: 1527-3792
CID: 3725822

Residual Pathological Stage at Radical Cystectomy Significantly Impacts Outcomes for Initial T2N0 Bladder Cancer COMMENT [Editorial]

Katz, Mark H.; Steinberg, Gary D.
ISI:000267850300014
ISSN: 0022-5347
CID: 3725622

Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker EDITORIAL COMMENT [Editorial]

Katz, Mark H.; Steinberg, Gary D.
ISI:000266949800018
ISSN: 0022-5347
CID: 3725612

Sequential Treatment Approach to Myoinvasive Urothelial Cancer: Phase II Southwest Oncology Group Trial (S0219) EDITORIAL COMMENT [Editorial]

Katz, Mark H.; Steinberg, Gary D.
ISI:000266020500024
ISSN: 0022-5347
CID: 3725602

Long-Term Oncological Outcomes in Women Undergoing Radical Cystectomy and Orthotopic Diversion for Bladder Cancer COMMENT [Editorial]

Steinberg, Gary D.
ISI:000265074800022
ISSN: 0022-5347
CID: 3725592

The Case Against Neoadjuvant Chemotherapy and Cystectomy for Muscle Invasive Bladder Cancer [Editorial]

Katz, Mark H.; Steinberg, Gary D.
ISI:000265074800007
ISSN: 0022-5347
CID: 3725582

The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer

deVere White, Ralph W; Katz, Mark H; Steinberg, Gary D
PMID: 19286209
ISSN: 1527-3792
CID: 3725982